Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 6 | 2017 | 69 | 1.030 |
Why?
|
| Bronchial Neoplasms | 2 | 2017 | 4 | 0.750 |
Why?
|
| Melanoma | 3 | 2017 | 16 | 0.710 |
Why?
|
| Humans | 35 | 2023 | 5837 | 0.660 |
Why?
|
| Middle Aged | 18 | 2018 | 1775 | 0.610 |
Why?
|
| Female | 23 | 2019 | 3346 | 0.610 |
Why?
|
| Sarcoma | 2 | 2017 | 19 | 0.580 |
Why?
|
| Biopsy | 4 | 2017 | 37 | 0.560 |
Why?
|
| Granulosa Cell Tumor | 2 | 2016 | 2 | 0.550 |
Why?
|
| Ovarian Neoplasms | 2 | 2016 | 11 | 0.540 |
Why?
|
| Biopsy, Needle | 9 | 2000 | 15 | 0.530 |
Why?
|
| Carcinoma | 3 | 2017 | 11 | 0.530 |
Why?
|
| Lymphoma | 2 | 2017 | 8 | 0.530 |
Why?
|
| Adult | 16 | 2019 | 1670 | 0.520 |
Why?
|
| Rhinitis | 3 | 2023 | 18 | 0.480 |
Why?
|
| Sinusitis | 3 | 2023 | 23 | 0.480 |
Why?
|
| Ovarian Cysts | 1 | 2016 | 1 | 0.480 |
Why?
|
| Granulomatous Mastitis | 1 | 2015 | 3 | 0.450 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2018 | 17 | 0.440 |
Why?
|
| Cell Nucleus | 2 | 2014 | 18 | 0.430 |
Why?
|
| Hemangiosarcoma | 1 | 2014 | 2 | 0.410 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 2 | 0.410 |
Why?
|
| Angiolipoma | 1 | 2014 | 2 | 0.410 |
Why?
|
| Adipocytes | 1 | 2014 | 3 | 0.410 |
Why?
|
| Hemangioma | 1 | 2014 | 4 | 0.410 |
Why?
|
| Cytoplasm | 1 | 2014 | 15 | 0.410 |
Why?
|
| Stromal Cells | 1 | 2014 | 21 | 0.410 |
Why?
|
| Skin Neoplasms | 5 | 2017 | 19 | 0.400 |
Why?
|
| Meningeal Neoplasms | 2 | 2008 | 3 | 0.390 |
Why?
|
| Male | 17 | 2018 | 3399 | 0.370 |
Why?
|
| Retrospective Studies | 9 | 2023 | 584 | 0.360 |
Why?
|
| Pancreatic Neoplasms | 2 | 2008 | 15 | 0.330 |
Why?
|
| Alphapapillomavirus | 1 | 2009 | 3 | 0.310 |
Why?
|
| Papilloma | 1 | 2009 | 3 | 0.310 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 5 | 0.310 |
Why?
|
| Ependymoma | 1 | 2009 | 2 | 0.300 |
Why?
|
| Cytological Techniques | 1 | 2009 | 3 | 0.300 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2009 | 4 | 0.300 |
Why?
|
| Paranasal Sinuses | 2 | 2020 | 16 | 0.300 |
Why?
|
| Meningioma | 1 | 2008 | 4 | 0.280 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2008 | 3 | 0.270 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 24 | 0.260 |
Why?
|
| Biopsy, Fine-Needle | 4 | 2016 | 7 | 0.260 |
Why?
|
| Organ Transplantation | 2 | 2005 | 14 | 0.260 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2005 | 4 | 0.240 |
Why?
|
| Carcinoid Tumor | 1 | 2006 | 1 | 0.240 |
Why?
|
| Neuroendocrine Tumors | 1 | 2006 | 10 | 0.230 |
Why?
|
| Lung Neoplasms | 4 | 2012 | 87 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2017 | 29 | 0.230 |
Why?
|
| Immunohistochemistry | 4 | 2017 | 71 | 0.230 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 27 | 0.220 |
Why?
|
| Postoperative Complications | 2 | 2005 | 154 | 0.210 |
Why?
|
| Immunocompromised Host | 2 | 2019 | 12 | 0.210 |
Why?
|
| Aged | 10 | 2017 | 1860 | 0.210 |
Why?
|
| Kidney Neoplasms | 4 | 2017 | 21 | 0.200 |
Why?
|
| Nasal Polyps | 1 | 2023 | 6 | 0.190 |
Why?
|
| Scalp | 2 | 2000 | 2 | 0.190 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 23 | 0.190 |
Why?
|
| Aged, 80 and over | 7 | 2017 | 1034 | 0.190 |
Why?
|
| Breast Diseases | 2 | 1999 | 3 | 0.180 |
Why?
|
| Neoplasms | 2 | 1999 | 39 | 0.170 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2019 | 2 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2019 | 7 | 0.150 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2017 | 13 | 0.150 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 1999 | 2 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2017 | 11 | 0.150 |
Why?
|
| Young Adult | 2 | 2018 | 421 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 125 | 0.150 |
Why?
|
| Firmicutes | 1 | 2018 | 3 | 0.140 |
Why?
|
| Bacteroidetes | 1 | 2018 | 3 | 0.140 |
Why?
|
| Tongue Neoplasms | 1 | 2018 | 7 | 0.140 |
Why?
|
| Neutrophils | 1 | 2018 | 31 | 0.140 |
Why?
|
| Microbiota | 1 | 2018 | 19 | 0.140 |
Why?
|
| HIV Infections | 1 | 1999 | 135 | 0.130 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2017 | 3 | 0.130 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 3 | 0.130 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 3 | 0.130 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 2 | 0.130 |
Why?
|
| Tonsillar Neoplasms | 1 | 2017 | 2 | 0.130 |
Why?
|
| Carcinoma, Embryonal | 1 | 2017 | 2 | 0.130 |
Why?
|
| Thymoma | 1 | 2017 | 3 | 0.130 |
Why?
|
| Thymus Neoplasms | 1 | 2017 | 3 | 0.130 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 10 | 0.130 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 14 | 0.130 |
Why?
|
| Adolescent | 4 | 2018 | 488 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2017 | 54 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 62 | 0.120 |
Why?
|
| Chronic Disease | 3 | 2023 | 71 | 0.120 |
Why?
|
| Melanosis | 1 | 1995 | 1 | 0.120 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 1995 | 2 | 0.120 |
Why?
|
| Peritoneal Neoplasms | 1 | 1995 | 2 | 0.120 |
Why?
|
| Ultrasonography, Mammary | 1 | 2015 | 7 | 0.110 |
Why?
|
| Mammography | 1 | 2015 | 13 | 0.110 |
Why?
|
| Neoplasm Staging | 4 | 2018 | 74 | 0.110 |
Why?
|
| Chondromatosis, Synovial | 1 | 1994 | 1 | 0.100 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 1994 | 2 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 11 | 0.100 |
Why?
|
| Prognosis | 3 | 2012 | 138 | 0.100 |
Why?
|
| Genes, p16 | 1 | 2012 | 4 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 37 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2012 | 72 | 0.090 |
Why?
|
| Ploidies | 1 | 1990 | 3 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 1990 | 5 | 0.080 |
Why?
|
| Rhabdomyosarcoma | 1 | 2009 | 2 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 26 | 0.080 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2009 | 8 | 0.080 |
Why?
|
| Follow-Up Studies | 4 | 2000 | 333 | 0.080 |
Why?
|
| Genotype | 1 | 2009 | 114 | 0.080 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 1988 | 1 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1988 | 1 | 0.070 |
Why?
|
| Parathyroid Neoplasms | 1 | 1988 | 2 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 1 | 1988 | 6 | 0.070 |
Why?
|
| Adenoma | 2 | 2006 | 6 | 0.070 |
Why?
|
| Granulosa Cells | 1 | 2008 | 1 | 0.070 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2006 | 1 | 0.060 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2006 | 3 | 0.060 |
Why?
|
| Glucuronidase | 1 | 2006 | 2 | 0.060 |
Why?
|
| Cytogenetics | 1 | 2006 | 1 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2006 | 32 | 0.060 |
Why?
|
| Survival Rate | 2 | 2018 | 60 | 0.060 |
Why?
|
| Age Factors | 2 | 2018 | 181 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2018 | 601 | 0.050 |
Why?
|
| Endoscopy | 1 | 2023 | 28 | 0.050 |
Why?
|
| Kidney Transplantation | 2 | 2019 | 22 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 30 | 0.040 |
Why?
|
| Carcinosarcoma | 1 | 2000 | 1 | 0.040 |
Why?
|
| Kidney Pelvis | 1 | 2000 | 5 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2000 | 23 | 0.040 |
Why?
|
| Smoking | 1 | 2020 | 47 | 0.040 |
Why?
|
| Mycobacterium xenopi | 1 | 2019 | 2 | 0.040 |
Why?
|
| Hyperplasia | 1 | 1999 | 3 | 0.040 |
Why?
|
| Metaplasia | 1 | 2018 | 4 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 16 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 14 | 0.040 |
Why?
|
| Biodiversity | 1 | 2018 | 7 | 0.040 |
Why?
|
| Disease Progression | 1 | 2018 | 157 | 0.030 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1997 | 2 | 0.030 |
Why?
|
| Breast | 1 | 1997 | 5 | 0.030 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Cadherins | 1 | 2017 | 11 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 13 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2017 | 12 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 37 | 0.030 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 1996 | 1 | 0.030 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1996 | 1 | 0.030 |
Why?
|
| Lung Diseases, Interstitial | 1 | 1996 | 2 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1996 | 11 | 0.030 |
Why?
|
| Thyroid Nodule | 1 | 1995 | 2 | 0.030 |
Why?
|
| Scalp Dermatoses | 1 | 1995 | 2 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 7 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 2012 | 7 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 35 | 0.020 |
Why?
|
| Illinois | 1 | 2012 | 52 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 28 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1991 | 1 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 1991 | 2 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1991 | 30 | 0.020 |
Why?
|
| Survival Analysis | 1 | 1990 | 37 | 0.020 |
Why?
|
| DNA, Antisense | 1 | 2006 | 1 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 31 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2006 | 43 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2006 | 43 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 63 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2006 | 139 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2000 | 150 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 13 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1997 | 2 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1997 | 3 | 0.010 |
Why?
|
| Databases as Topic | 1 | 1997 | 2 | 0.010 |
Why?
|
| Mastectomy | 1 | 1997 | 6 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1997 | 14 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 163 | 0.010 |
Why?
|
| Lip Neoplasms | 1 | 1996 | 1 | 0.010 |
Why?
|
| Heart-Lung Transplantation | 1 | 1996 | 1 | 0.010 |
Why?
|
| Muromonab-CD3 | 1 | 1996 | 1 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 1996 | 2 | 0.010 |
Why?
|
| Heart Neoplasms | 1 | 1996 | 3 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1996 | 15 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1996 | 5 | 0.010 |
Why?
|
| Goiter, Nodular | 1 | 1995 | 1 | 0.010 |
Why?
|
| Thyroiditis | 1 | 1995 | 1 | 0.010 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 1995 | 2 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 1995 | 5 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1995 | 14 | 0.010 |
Why?
|
| Dermatology | 1 | 1995 | 1 | 0.010 |
Why?
|
| Medical Oncology | 1 | 1995 | 10 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1995 | 174 | 0.010 |
Why?
|
| Incidence | 1 | 1995 | 165 | 0.010 |
Why?
|
| Child | 1 | 1995 | 339 | 0.010 |
Why?
|